GlassScriptPhysician profile
Tracey Culbertson
NPI 1902808538
$2,517.11
in general payments reported to CMS, 2019-2025
14 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $160 · 2022: $176 · 2023: $715 · 2024: $283 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $931.73 | 2019 | |
| Organogenesis INC. | $491.32 | 2020-2025 | Puraply, Affinity, Via Matrix |
| Convatec INC. | $458.21 | 2019-2025 | |
| Progenacare Global, LLC | $211.59 | 2023 | |
| Kerecis Limited | $73.85 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Aroa Biosurgery Incorporated | $73.68 | 2020 | |
| Solventum Corporation | $61.90 | 2025 | Activ.A.C., Promogran Prisma |
| Smith+Nephew, INC. | $47.82 | 2019-2024 | Collagenase Santyl |
| Bsn Medical INC | $45.84 | 2022 | |
| Integra Lifesciences Corporation | $33.20 | 2019-2022 | |
| Next Science LLC | $26.38 | 2024 | Xperience, Blastx, Surgx |
| Bioventus LLC | $25.65 | 2022 | |
| Ets Wound Care LLC | $20.43 | 2024 | Mirragen Advanced Wound Matrix |
| Janssen Pharmaceuticals, INC | $15.51 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Culbertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.